Ashley Frazer‐Abel

2.3k total citations
60 papers, 1.5k citations indexed

About

Ashley Frazer‐Abel is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Ashley Frazer‐Abel has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 17 papers in Molecular Biology and 12 papers in Hematology. Recurrent topics in Ashley Frazer‐Abel's work include Complement system in diseases (22 papers), Renal Diseases and Glomerulopathies (8 papers) and Retinal Diseases and Treatments (7 papers). Ashley Frazer‐Abel is often cited by papers focused on Complement system in diseases (22 papers), Renal Diseases and Glomerulopathies (8 papers) and Retinal Diseases and Treatments (7 papers). Ashley Frazer‐Abel collaborates with scholars based in United States, Hungary and Germany. Ashley Frazer‐Abel's co-authors include Michael Kirschfink, Zoltán Prohászka, Paul J. Hagerman, V. Michael Holers, Patricia C. Giclas, Jaime F. Modiano, Susan Fosmire, Steven J. Burakoff, Bo Nilsson and Jinyan Du and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Ashley Frazer‐Abel

56 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ashley Frazer‐Abel	550	461	199	172	169	60	1.5k
Monika Pruenster	628 1.1×	1.4k 3.0×	232 1.2×	115 0.7×	69 0.4×	35	2.4k
Markus Napirei	889 1.6×	1.4k 3.1×	170 0.9×	109 0.6×	66 0.4×	28	2.3k
Wenjie Zheng	393 0.7×	577 1.3×	282 1.4×	146 0.8×	73 0.4×	139	2.1k
Daniel Schimel	469 0.9×	138 0.3×	216 1.1×	256 1.5×	268 1.6×	18	1.4k
Paula Sandrin‐Garcia	507 0.9×	397 0.9×	101 0.5×	43 0.3×	115 0.7×	66	1.1k
Yasuo Mori	1.0k 1.9×	770 1.7×	252 1.3×	133 0.8×	160 0.9×	102	2.9k
Jonatan Leffler	363 0.7×	1.0k 2.3×	83 0.4×	62 0.4×	122 0.7×	34	1.4k
Winson W. Tang	1.1k 2.0×	633 1.4×	163 0.8×	197 1.1×	578 3.4×	31	2.8k
Federico Perosa	716 1.3×	1.0k 2.3×	262 1.3×	96 0.6×	67 0.4×	93	2.4k
Julie E. Niemela	410 0.7×	1.2k 2.7×	221 1.1×	222 1.3×	103 0.6×	65	2.0k

Countries citing papers authored by Ashley Frazer‐Abel

Since Specialization

Citations

This map shows the geographic impact of Ashley Frazer‐Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Frazer‐Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Frazer‐Abel more than expected).

Fields of papers citing papers by Ashley Frazer‐Abel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Frazer‐Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Frazer‐Abel. The network helps show where Ashley Frazer‐Abel may publish in the future.

Co-authorship network of co-authors of Ashley Frazer‐Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Frazer‐Abel. A scholar is included among the top collaborators of Ashley Frazer‐Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Frazer‐Abel. Ashley Frazer‐Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCaleb, Michael L., Steven G. Hughes, Tamar R. Grossman, et al.. (2025). Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen. Immunobiology. 230(2). 152876–152876. 2 indexed citations

Webb‐Robertson, Bobbie‐Jo, Hemang Parikh, Ernesto Nakayasu, et al.. (2025). Genetic mapping of complement system proteins for islet autoimmunity in children with high risk of T1D. Communications Biology. 8(1). 1366–1366. 1 indexed citations

Feng, Changyong, Ashley Frazer‐Abel, Roberta Gonçalves Marangoni, et al.. (2024). Utility of factor D and other alternative complement factors as biomarkers in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH). Seminars in Arthritis and Rheumatism. 69. 152554–152554.

Kirschfink, Michael, et al.. (2024). External quality assurance program for diagnostic complement laboratories: evaluation of the results of the past seven years. Frontiers in Immunology. 15. 1368399–1368399. 3 indexed citations

Webb‐Robertson, Bobbie‐Jo, Ernesto Nakayasu, Fran Dong, et al.. (2023). Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes. iScience. 27(2). 108769–108769. 8 indexed citations

Melchior, John, Ashley Frazer‐Abel, Bobbie‐Jo Webb‐Robertson, et al.. (2023). Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response. Clinical Proteomics. 20(1). 38–38. 15 indexed citations

McBride, Helen J., Ashley Frazer‐Abel, Sandra Thiemann, et al.. (2023). Functional similarity of ABP 959 and eculizumab in simulated serum models of aHUS and NMOSD. Annals of Hematology. 102(12). 3299–3309. 4 indexed citations

Barbour, Sean, Michelle Hladunewich, Angela Makris, et al.. (2022). An Exploratory Trial of an Investigational RNA Therapeutic, IONIS-FB-LRx, for Treatment of IgA Nephropathy. Journal of the American Society of Nephrology. 33(11S). 800–800. 4 indexed citations

Knight, Vijaya, Patricia Merkel, Molly M. Lamb, et al.. (2022). COVID-19 Serology Control Panel Using the Dried-Tube Specimen Method. American Journal of Tropical Medicine and Hygiene. 106(2). 562–565.

10.

Knight, Vijaya, Jennifer Heimall, Hey Chong, et al.. (2021). A Toolkit and Framework for Optimal Laboratory Evaluation of Individuals with Suspected Primary Immunodeficiency. The Journal of Allergy and Clinical Immunology In Practice. 9(9). 3293–3307.e6. 11 indexed citations

11.

Sabourin, Katherine R., Jonathan Schultz, Joshua Romero, et al.. (2020). Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders—The COVID-19 Arapahoe SErosurveillance Study (CASES) Project. Journal of Occupational and Environmental Medicine. 63(3). 191–198. 10 indexed citations

12.

Bemis, Elizabeth A., Jill M. Norris, Jennifer Seifert, et al.. (2019). Complement and its environmental determinants in the progression of human rheumatoid arthritis. Molecular Immunology. 112. 256–265. 33 indexed citations

13.

Thurman, Joshua M., Ashley Frazer‐Abel, & V. Michael Holers. (2017). Review: The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases. Arthritis & Rheumatology. 69(11). 2102–2113. 20 indexed citations

14.

Frazer‐Abel, Ashley, et al.. (2016). Overview of Laboratory Testing and Clinical Presentations of Complement Deficiencies and Dysregulation. Advances in clinical chemistry. 77. 1–75. 33 indexed citations

15.

Kartalija, Marinka, Alida R. Ovrutsky, Gregory B. Pott, et al.. (2012). Patients with Nontuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes. American Journal of Respiratory and Critical Care Medicine. 187(2). 197–205. 169 indexed citations

16.

Oloris, Sı́lvia Catarina Salgado, Ashley Frazer‐Abel, Cristan M. Jubala, et al.. (2009). Nicotine-mediated signals modulate cell death and survival of T lymphocytes. Toxicology and Applied Pharmacology. 242(3). 299–309. 25 indexed citations

17.

Frazer‐Abel, Ashley, et al.. (2006). Cigarette tar phenols impede T cell cycle progression by inhibiting cyclin-dependent kinases. Molecular Immunology. 44(4). 488–493. 4 indexed citations

18.

Frazer‐Abel, Ashley, Shairaz Baksh, Susan Fosmire, et al.. (2004). Nicotine Activates Nuclear Factor of Activated T Cells c2 (NFATc2) and Prevents Cell Cycle Entry in T Cells. Journal of Pharmacology and Experimental Therapeutics. 311(2). 758–769. 24 indexed citations

19.

Chang, Mei‐Ping, Alexander J. Wolf, Ashley Frazer‐Abel, et al.. (1997). Cdc73p and Paf1p Are Found in a Novel RNA Polymerase II-Containing Complex Distinct from the Srbp-Containing Holoenzyme. Molecular and Cellular Biology. 17(3). 1160–1169. 128 indexed citations

20.

Schweppe, Rebecca E., Ashley Frazer‐Abel, Arthur Gutierrez‐Hartmann, & Andrew P. Bradford. (1997). Functional Components of Fibroblast Growth Factor (FGF) Signal Transduction in Pituitary Cells. Journal of Biological Chemistry. 272(49). 30852–30859. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact